This Series paper supports SDGs 3 and 10 by summarising the state of knowledge on inequalities in care delivery and outcomes for patients with cardiovascular disease in the UK
This Article supports SDG 3 by estimating the burden of rheumatoid arthritis. Finding include that the rate of years lived with disability due to rheumatoid arthritis increased by 13.8% from 1990 to 2020. The authors note that outcomes including severity of disability can be improved by early diagnosis and access to DMARD therapy.
Elsevier,

Clinician's Guide to Sexuality and Autism
A Guide to Sex Education for Individuals with Autism Spectrum Disorders
2024, Pages 9-16

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by outlining how to use the book to provide effective teaching in sexuality education with an emphasis on individualization for specific learners.
Elsevier,

Clinician's Guide to Sexuality and Autism
A Guide to Sex Education for Individuals with Autism Spectrum Disorders
2024, Pages 3-8

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by introducing sexuality education curriculum for learners of all ages with autism.
Elsevier,

Manson's Tropical Diseases (Twentyfourth Edition)
2024, Pages 139-151

This content aligns with Goal 3: Good Health and Wellbeing by presenting the current evidence for HIV/AIDS prevention.
Elsevier,

Manson's Tropical Diseases (Twentyfourth Edition)
2024, Pages 101-109

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by providing information about access to evidence-based treatment and prevention interventions as well as addressing the underlying social, political and economic issues, such as poverty, lack of access to healthcare, and stigma and discrimination that contribute to the high burden of HIV in the region
Elsevier,

Manson's Tropical Diseases (Twentyfourth Edition), 2024, Pages 11-19

With a pressing climate emergency and increasing interconnectedness, the need for action on health at a global level is greater than ever. Achieving Universal Health Coverage with a strong base in primary healthcare is essential. This must be accompanied by policies to address the socioeconomic and environmental determinants of ill health, supporting SDG3.
Elsevier,

Reproductive BioMedicine Online, Available online 12 October 2023, 103600

This article ties with climate action and reproductive medicine, as it is a reflexion on healthcare carbon footprint especially the IVF laboratories.
WHO recommends dolutegravir as the preferred anchor drug for first-line and second-line HIV treatment, and is being rolled out globally. This study shows that dolutegravir is safe but clinicians should nonetheless be aware of the risk of psychiatric manifestations in children and adolescents taking the drug.
This Article supports SDG 3 by showing, through a modelling analysis, that community tenofovir, lamivudine, and dolutegravir (TLD) is likely to reduce HIV incidence and be cost-effective, thus leading to population health benefits.

Pages